PHARMACOVIGILANCE 2010

Virtue Insight is organizing a Pharmacovigilance conference in Mumbai on January 21-22 2010 on 'Overseeing risks & Optimizing drug safety in todays Pharma Market'

Conference Introduction

Pharmacovigilance is the science and actions unfolding to discovery, evaluation, understanding and prevention of adverse effects or any  other likely medicine related problem. It aims to make use of medicines for the treatment or prevention of diseases. Though it is not intended to harm the patients during medicine use process, unfortunately some medicines often create slight or serious problems. Significant harm to even a few patients not only destroys the credibility of the medicine, the patients tend to loose trust on the the health system. A good Pharmacovigilance will identify the risks in the shortest possible time so that the harm can be avoided or minimized. The most frightening thought for any pharma company is the prospect of a drug withdrawal. As the costs associated with product withdrawals escalate the importance of pharmacovigilance increases.

Pharmacovigilance 2010 will discuss the on-going pressing concerns faced in drug safety, addressing the risks, timeline and budget constraint, whilst effectively tackling key challenges in overcoming trials agreement and site contract negotiation hurdles. This conference brings together top pharmaceutical, biotechnology and regulatory representatives in a forum that addresses the key issues of the industry. The in-depth program covers the detection, analysis and prevention of adverse drug reactions with case studies and industry experiences. Understand and learn the latest insights, tools and knowledge to ensure that you and your firm to catch up with the current and future market. Analyze along with the market leaders on the latest developments in pharmacovigiance which would shape your organization's wide risk management strategy.

For more information, click here to download the draft brochure